Dipti Sahoo joined Silk Road Medical in 2020 and brings over 20 years of experience executing clinical programs globally across multi-national corporations and venture backed start-ups in the medical device industry, as well as in academic research. Prior to joining Silk Road, Dipti led clinical evidence development at Velano Vascular (acquired by Becton Dickinson) after building a consulting business for clinical affairs and clinical marketing services with 12+ medical device clients over 3 years. She has held positions of increasing responsibility at Intersect ENT (acquired by Medtronic) by expanding their ENT bioresorbable clinical programs during the post-IPO growth phase, and at Abbott Vascular where she managed clinical trials in the US, Europe and Asia for the coronary and peripheral vascular businesses. Dipti holds a MSc in Public Health from the London School of Hygiene & Tropical Medicine (LSHTM) and a BA in Biological Basis for Behavior from UPenn.